TheChineTime

Amid obesity push, Pfizer strikes deal worth up to $495M to market Sciwind's approved GLP-1 in China - Fierce Pharma

2026-02-24 - 18:03

Amid obesity push, Pfizer strikes deal worth up to $495M to market Sciwind's approved GLP-1 in China Fierce Pharma

Share this post: